Making an impact on AMR R&DAt the 11th Berlin Conference, Novo Holdings outlined details of a new €135m investment fund launched to push the development of new drug classes urgently needed to fight antimicrobial resistance. … more ➔
Learning to listen to your gutThe adage you are what you eat’ is more than folk wisdom. Evidence that the food you ingest has a major impact on your health grows by the day. It’s now clear the bacteria that colonise the skin and … more ➔
packaging, Pharmapack Experts forecast the industry’s bigg...Personalised medicines, intelligent packaging and FDA deadlines seen as major trends for pharma packaging in 2018. more ➔
App design for the cellular processorSince the earliest attempts at genetic engineering, scientists have sought to influence cell behaviour and development through the introduction of foreign genetic material. Synthetic biologists are now … more ➔
Plasmodium locked inFor decades, researchers have searched without success for a strategy to prevent malaria. Now, two teams of researchers present a solution that circumvents the problem of surface antigen hypervariability … more ➔
Spanish biotech sector attracts investorsSpanish biotech sector:?European investors more and more often take a look at Southern European biotech companies. Spain, in particular, is now harvesting the fruits of long-term public support started … more ➔
EU ombudsman soft-sells safety concerns on...A complaint against the EMA’s handling of a referral procedure related to potential side effects of Sanofi/MSD’s HPV vaccine Gardasil and GSK’s HPV jab Cervarix, filed by the Nordic Cochrane Centre and … more ➔
New wave of optimism for European biotech...The European biotech stock market witnessed an increase in IPO and follow-on financing volumes in 2017. According to the new BIOCOM capital market report, published in November during BIO-Europe in Berlin, … more ➔
European bioeconomy entering the next leve...A series of high-level conferences held in autumn and winter focused on current challenges to implementing an industrial scale bioeconomy in Europe. In November, the European Commission unveiled a new … more ➔
berlinconference, KMU New momentum for SMEsAntimicrobial resistance:?In 2017, the development of new drugs and diagnostics to combat multidrug-resistant pathogens gained momentum in Europe. Small and medium-sized companies (SMEs) successfully … more ➔
